|
PASG Passage Bio Inc 1787297 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-7,559,000.00 |
| Balance Sheet |
|
Current Assets
|
$34,741,000.00 |
|
Assets
|
$36,462,000.00 |
|
Current Liabilities
|
$20,104,000.00 |
|
Liabilities
|
$24,710,000.00 |
|
Equity
|
$11,752,000.00 |
|
Shares Out
|
3207810.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-12,987,000.00 |
|
Investing Cash Flow
|
$20,000.00 |
| Market Analysis |
Market Cap
|
$14,403,066.90 |
|
Price
|
$4.33 |
|
BVPS
|
3.66 |
|
PB
|
1.23 |
|
EPS
|
-2.36 |
|
FCF
|
$-13,021,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:43 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:43 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-2.96 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-10 |
-2.44 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PASG documents filed with the SEC.
PASG Filings
Clear
